Primecap Management CO Bio N Tech Se Transaction History
Primecap Management CO
- $136 Billion
- Q2 2024
A detailed history of Primecap Management CO transactions in Bio N Tech Se stock. As of the latest transaction made, Primecap Management CO holds 4,789,518 shares of BNTX stock, worth $542 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
4,789,518
Previous 4,807,918
0.38%
Holding current value
$542 Million
Previous $444 Million
13.22%
% of portfolio
0.28%
Previous 0.34%
Shares
19 transactions
Others Institutions Holding BNTX
# of Institutions
326Shares Held
39.1MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$937 Million0.53% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$496 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$331 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$215 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.15MShares$130 Million0.01% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...